Extract from the Register of European Patents

EP About this file: EP1228039

EP1228039 - N-GUANIDINOALKYLAMIDES, THEIR PREPARATION, THEIR USE, AND PHARMACEUTICAL PREPARATIONS COMPRISING THEM [Right-click to bookmark this link]
StatusNo opposition filed within time limit
Status updated on  25.02.2005
Database last updated on 11.04.2026
Most recent event   Tooltip23.09.2005Lapse of the patent in a contracting statepublished on 09.11.2005  [2005/45]
Applicant(s)For all designated states
Aventis Pharma Deutschland GmbH
Brüningstrasse 50
65929 Frankfurt am Main / DE
[2002/32]
Inventor(s)01 / KLINGLER, Otmar
Leipziger Ring 363
63110 Rodgau / DE
02 / ZOLLER, Gerhard
Höhenstrasse 8
61137 Schöneck / DE
03 / DEFOSSA, Elisabeth
Stolzwiese 20
65510 Idstein / DE
04 / AL-OBEIDI, Fahad
6798 N. Corte Calabaza
Tucson, AZ 85704 / US
05 / WALSER, Armin
5900 N. Camino Miraval
Tucson, AZ 85718 / US
06 / OSTREM, James
1202 E. Chula Vista
Tucson, AZ 85718 / US
 [2002/38]
Former [2002/32]01 / KLINGLER, Otmar
Leipziger Ring 363
63110 Rodgau / DE
02 / ZOLLER, Gerhard
Höhenstrasse 8
61137 Schöneck / DE
03 / DEFOSSA, Elisabeth
Stolzwiese 20
65510 Idstein / DE
04 / AL-OBEIDI, Fahad
548 E. Wine Plum Drive
Tucson, AZ 85704 / US
05 / WALSER, Armin
5900 N. Camino Miraval
Tucson, AZ 85718 / US
06 / OSTREM, James
1202 E. Chula Vista
Tucson, AZ 85718 / US
Application number, filing date00971396.721.10.2000
[2002/32]
WO2000EP10395
Priority number, dateEP1999012162330.10.1999         Original published format: EP 99121623
[2002/32]
Filing languageEN
Procedural languageEN
PublicationType: A1 Application with search report
No.:WO0132611
Date:10.05.2001
Language:EN
[2001/19]
Type: A1 Application with search report 
No.:EP1228039
Date:07.08.2002
Language:EN
The application published by WIPO in one of the EPO official languages on 10.05.2001 takes the place of the publication of the European patent application.
[2002/32]
Type: B1 Patent specification 
No.:EP1228039
Date:21.04.2004
Language:EN
[2004/17]
Search report(s)International search report - published on:EP10.05.2001
ClassificationIPC:C07C279/14, A61K31/16
[2002/32]
CPC:
C07D213/30 (EP,KR,US); A61P11/00 (EP); A61P29/00 (EP);
A61P43/00 (EP); A61P7/02 (EP); A61P9/00 (EP);
A61P9/10 (EP); C07C279/14 (EP,KR,US); C07D213/40 (EP,KR,US);
C07D215/233 (KR); C07D215/48 (EP,KR,US); C07D239/28 (EP,KR,US);
C07D239/34 (KR) (-)
Designated contracting statesAT,   BE,   CH,   CY,   DE,   DK,   ES,   FI,   FR,   GB,   GR,   IE,   IT,   LI,   LU,   MC,   NL,   PT,   SE [2002/32]
Extension statesAL31.05.2002
LT31.05.2002
LV31.05.2002
MK31.05.2002
RO31.05.2002
SI31.05.2002
TitleGerman:N-GUANIDINALKYLAMIDE, VERFAHREN ZU IHRER HERSTELLUNG UND SIE ENTHALTENDE PHARMAZEUTISCHE PRÄPARATE[2002/32]
English:N-GUANIDINOALKYLAMIDES, THEIR PREPARATION, THEIR USE, AND PHARMACEUTICAL PREPARATIONS COMPRISING THEM[2002/32]
French:N-GUANIDINOALKYLAMIDES, LEUR PREPARATION, LEUR UTILISATION, ET PREPARATIONS PHARMACEUTIQUES RENFERMANT CEUX-CI[2002/32]
Entry into regional phase31.05.2002National basic fee paid 
31.05.2002Designation fee(s) paid 
31.05.2002Examination fee paid 
Examination procedure17.05.2001Request for preliminary examination filed
International Preliminary Examining Authority: EP
31.05.2002Examination requested  [2002/32]
12.08.2003Communication of intention to grant the patent
23.02.2004Fee for grant paid
23.02.2004Fee for publishing/printing paid
Opposition(s)24.01.2005No opposition filed within time limit [2005/15]
Fees paidRenewal fee
31.10.2002Renewal fee patent year 03
31.10.2003Renewal fee patent year 04
Opt-out from the exclusive  Tooltip
competence of the Unified
Patent Court
See the Register of the Unified Patent Court for opt-out data
Responsibility for the accuracy, completeness or quality of the data displayed under the link provided lies entirely with the Unified Patent Court.
Lapses during opposition  TooltipMC31.10.2004
[2005/45]
The EPO accepts no responsibility for the accuracy of data originating from other authorities; in particular, it does not guarantee that it is complete, up to date or fit for specific purposes.